Panbela to participate in a panel discussion: “pancreatic cancer- turning the tide for one of the most challenging indications in oncology,” at the maxim virtual growth conference on march 28, 2022, at 12:00 pm et

Minneapolis, march 23, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announced today that management will participate in a panel discussion titled, “pancreatic cancer- turning the tide for one of the most challenging indications in oncology,” at the maxim virtual growth conference on march 28, 2022, at 12:00 pm et.
PBLA Ratings Summary
PBLA Quant Ranking